Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus

Authors

  • Clarissa Cordeiro Alves Arrelias Universidade de São Paulo, Hospital das Clinicas, Faculdade de Medicina de Ribeirão Preto
  • Fernando Belissimo Rodrigues Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto
  • Maria Teresa da Costa Gonçalves Torquato Prefeitura Municipal de Ribeirão Preto, Secretaria Municipal de Saúde
  • Carla Regina de Souza Teixeira Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto
  • Flávia Fernanda Luchetti Rodrigues Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto
  • Maria Lucia Zanetti Universidade de São Paulo, Escola de Enfermagem de Ribeirão Preto https://orcid.org/0000-0003-1656-6626

DOI:

https://doi.org/10.1590/1518-8345.2774.3085

Keywords:

Diabetes Mellitus, Hepatitis B, Hepatitis C, Immunization Coverage, Liver Diseases, Nursing

Abstract

Objective: to estimate the prevalence of serological markers for hepatitis B and C in patients with diabetes mellitus and analyze potential associated factors. Method: a cross-sectional study with 255 patients with diabetes mellitus. Demographic, clinical, and risk behavior factors for hepatitis B and C were selected. The markers HBsAg, Anti-HBc IgG, Anti-HBc IgM, Anti-HBs, and Anti-HCV were investigated. A questionnaire and venous blood collection and inferential statistical analysis were used. Results: 16.8% of the patients had a total reactive Anti-HBc marker, 8.2% an isolated Anti-HBs, and 75% were non-reactive for all hepatitis B markers. No case of reactive HBsAg was found and 3.3% of the patients had a reactive anti-HCV marker. The prevalence of prior hepatitis B virus infection was directly associated with the time of diabetes mellitus and the prevalence of hepatitis C virus infection was not associated with the investigated variables. The prevalence of hepatitis B and C infection in patients with diabetes mellitus was higher when compared to the national, with values of 16.8% and 3.3%, respectively. Conclusion: the results suggest that patients with diabetes are a population of higher vulnerability to hepatitis B and C, leading to the adoption of preventive measures of their occurrence.

Downloads

Download data is not yet available.

Downloads

Published

2019-04-02

Issue

Vol. 26 (2018)

Section

Original Articles

License

RLAE’s authorship concept is based on the substantial contribution by each of the individuals listed as authors, mainly in terms of conceiving and planning the research project, collecting or analyzing and interpreting data, writing and critical review. Indication of authors’ names under the article title is limited to six. If more, authors are listed on the online submission form under Acknowledgements. The possibility of including more than six authors will only be examined on multicenter studies, considering the explanations presented by the authors.
Including names of authors whose contribution does not fit into the above criteria cannot be justified. Those names can be included in the Acknowledgements section.
 Authors are fully responsible for the concepts disseminated in their manuscripts, which do not necessarily reflect the editors’ and editorial board’s opinion.

 

How to Cite

Arrelias, C. C. A., Rodrigues, F. B., Torquato, M. T. da C. G., Teixeira, C. R. de S., Rodrigues, F. F. L., & Zanetti, M. L. (2019). Prevalence of serological markers for hepatitis and potential associated factors in patients with diabetes mellitus. Revista Latino-Americana De Enfermagem, 26, e3085. https://doi.org/10.1590/1518-8345.2774.3085